Johnson & Johnson, Currently the Pharmaceutical Company with the Largest Market Capitalization

Johnson & Johnson, an American pharmaceutical company, had a market capitalization of US$419.10 billion in November 2021. According to data from companiesmarket.com, this made Johnson & Johnson the world's largest pharmaceutical company by market capitalization.

According to Johnson & Johnson's latest financial report, the company's current revenue is US$91.44 billion. In 2020, the company earned US$82.58 billion in revenue, an increase from US$82.05 billion in 2019.

The second-largest pharmaceutical company by market capitalization is Roche. The Swiss company currently has a market capitalization of US$331.69 billion.

Next are two American pharmaceutical companies, Pfizer and Eli Lilly, with market capitalizations of US$303.09 billion and US$249.06 billion, respectively. Following them is the Danish company Novo Nordisk, with a market capitalization of US$246.74 billion.

AbbVie and Merck, two American companies, have market capitalizations of US$205.97 billion and US$199.95 billion, respectively. The next largest pharmaceutical companies are Novartis (Swiss) with US$180.53 billion, AstraZeneca (UK) with US$175.30 billion, and Moderna (US) with US$133.64 billion.